ATPCNasdaqServices-Health ServicesFiscal year ends December 31
Agape ATP Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.56−0.01 (-0.64%)
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$57.44 (−97.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Agape ATP Corp saw revenue fall 20.3% to $1.15M over the twelve months to Jun 30, 2026.
Revenue
$1.15M
-20.3% vs. a year earlier
Operating income
-$3.13M
TTM Q2 2026
EPS, diluted
-$2.85
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.56M
- P/E ratio
- –
- Price to sales
- 1.35
- Price to book
- 0.07
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.15M
- Net income
- -$1.16M
- EPS, diluted
- -$2.85
- Book value per share
- $22.04
- Diluted shares
- 1M
Nine years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$1.15M-20.3% YoY
Gross profit
$644.22K+10.3% YoY
Operating income
-$3.13M
Net income
-$1.16M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months